Calithera Biosciences Receives $27,150,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=854aa6cf-225d-461f-a023-e292912525ff
Date
10/25/2013
Company Name
Calithera Biosciences
Mailing Address
343 Oyster Point Blvd. South San Francisco, CA 94080
Company Description
The primary mission of Calithera Biosciences is to develop novel therapeutic approaches to the treatment of cancer by using small molecules to activate, rather than inhibit, enzymes. Our first program is focused on developing activators of caspases, the proteases that induce apoptosis, for the treatment of cancer.
Website
http://www.calithera.com
Transaction Type
Venture Equity
Transaction Amount
$27,150,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for any solicitation details, if applicable.
M&A Terms
Venture Investor
Undisclosed